VENUS REMEDIES
Back to Income Statement
|
VENUS REMEDIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹45 Cr | ₹28 Cr | ₹27 Cr | ₹41 Cr | ₹62 Cr |
What is the latest Consolidated Net Profit of VENUS REMEDIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹45 Cr |
| Mar2024 | ₹28 Cr |
| Mar2023 | ₹27 Cr |
| Mar2022 | ₹41 Cr |
| Mar2021 | ₹62 Cr |
How is Consolidated Net Profit of VENUS REMEDIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹45 Cr | 59.05 | |
| Mar2024 | ₹28 Cr | 7.25 | |
| Mar2023 | ₹27 Cr | -34.77 | |
| Mar2022 | ₹41 Cr | -34.07 | |
| Mar2021 | ₹62 Cr | - | |
Compare Consolidated Net Profit of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,058.5 Cr | 3.6% | 9.5% | 134% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,717.0 Cr | 0.6% | 7% | 1.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,830.0 Cr | 1.6% | 4.6% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,479.0 Cr | 3.1% | 5.9% | 39% | Stock Analytics | |
| CIPLA | ₹108,978.0 Cr | 1.5% | -2.1% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,905.0 Cr | 0.5% | 9.8% | 5.7% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 3.6% |
9.5% |
134% |
| SENSEX | -0.6% |
0.6% |
9.8% |
You may also like the below Video Courses